Shuttle Pharmaceuticals Holdings, Inc.
SHPHNasdaqCIK 1757499HealthcareFiscal year ends Dec 31
Reports and events: 148 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-04-0416:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-002757 |
| 2025-03-3117:27 ET | DEF 14A | Proxy statementPeriod 2025-03-31 | 0001641172-25-001889 |
| 2025-03-3117:25 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-001880 |
| 2025-03-2516:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-000595 |
| 2025-03-1316:19 ET | 8-K | 1.01 Entry into a material agreement; 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-010211 |
| 2025-03-1206:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-009922 |
| 2025-03-0506:48 ET | S-1/A | Registration statement, amended | 0001493152-25-009106 |
| 2025-02-2817:24 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-008742 |
| 2025-02-2708:38 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-008462 |
| 2025-02-2610:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-008306 |
| 2025-02-2610:20 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001493152-25-008300 |
| 2025-02-1306:22 ET | S-1 | Registration statement | 0001493152-25-006202 |
| 2025-01-2816:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-003985 |
| 2025-01-2109:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-002945 |
| 2025-01-1506:37 ET | S-1 | Registration statement | 0001493152-25-002253 |
| 2025-01-0709:00 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-001132 |
| 2024-12-1909:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-050700 |
| 2024-11-2609:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-047747 |
| 2024-11-1317:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045199 |
| 2024-11-1317:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045176 |
| 2024-11-0120:57 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-043249 |
| 2024-10-2909:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-042786 |
| 2024-10-2816:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-042677 |
| 2024-10-2809:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-042614 |
| 2024-10-2508:52 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-042462 |
| 2024-10-1809:06 ET | S-1/A | Registration statement, amended | 0001493152-24-041510 |
| 2024-10-1717:17 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-041443 |
| 2024-09-2006:04 ET | S-1 | Registration statement | 0001493152-24-037194 |
| 2024-09-1317:00 ET | 8-K | 3.01 Delisting notice | 0001493152-24-036223 |
| 2024-09-1017:23 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-035667 |
| 2024-09-0416:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-034987 |
| 2024-09-0421:54 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-034902 |
| 2024-09-0421:52 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-03-31 | 0001493152-24-034901 |
| 2024-09-0421:51 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001493152-24-034898 |
| 2024-08-2809:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-034124 |
| 2024-08-2616:10 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-24-033876 |
| 2024-08-1416:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-032218 |
| 2024-08-0708:00 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-030491 |
| 2024-08-0109:45 ET | 8-K | 5.07 Shareholder vote results | 0001493152-24-029882 |
| 2024-07-1616:59 ET | 8-K | 4.02 Non-reliance on financial statements | 0001493152-24-028031 |
| 2024-06-2015:59 ET | DEF 14A | Proxy statementPeriod 2024-06-20 | 0001493152-24-024491 |
| 2024-06-1809:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-024224 |
| 2024-05-2216:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-021015 |
| 2024-05-1409:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-019097 |
| 2024-05-1317:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-018944 |
| 2024-04-2910:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-016875 |
| 2024-04-2316:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-015703 |
| 2024-04-0517:06 ET | S-1 | Registration statement | 0001493152-24-013368 |
| 2024-03-2209:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-010919 |
| 2024-03-2117:28 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-010822 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 18:28 ET. Listed shows no prices and gives no investment advice.